missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

anti-Androgen R/NR3C4 (p Ser213, p Ser210), Clone: 156C135.2, Novus Biologicals™

Manufacturer:  Novus Biologicals Canada NB10056603

 View more versions of this product

Catalog No. NB10056603


 

Disclaimers:

For Research Use Only


Specifications Description & Specifications

Specifications

Androgen R/NR3C4 (p Ser213
156C135.2
Unlabeled
P10275
Murine
κ
RUO
Monoclonal
In IGF-1 stimulated LNCaP cells (passage number 38), a ∽110 kDa band was observed. Please see Lin et al. 2003 for additional details. The serine phosphorylation site recognized by this antibody has been alternatively referred to Ser213 (Lee and Chang, 2003) and Ser210 (Lin et al, 2003). Variations in denotation can arise from how the sequence is counted in various GenBank accession numbers. The site is denoted as Ser213 in GenBank Accession No. A39248, which was used to design the immunogen. Human and New World Monkey. Predicted cross-reactivity with Chimpanzee, Dog, Mouse, Pig and Rat.
Immunohistochemistry,Immunohistochemistry (Paraffin),Western Blot
0.5mg/mL
0.2mL PBS containing 0.05% BSA
Purified
This antibody was developed against a synthetic peptide corresponding to amino acids 207-221 (GRAREAS*GAPTSSKD) of human androgen receptor, containing the serine 213 phosphorylation site: GenBank Accession No. A39248. Note: S* refers to phosphorylated serine in the peptide sequence.
0.1mg
Primary
367
Human,Primate